| Recruiting | Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State Type 1 Diabetes Mellitis | Phase 1 | 2025-10-13 |
| Recruiting | Comparison Study of Insulin GZR4 With Insulin Degludec Type 2 Diabetes | Phase 1 | 2025-08-15 |
| Not Yet Recruiting | Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants Obesity and Overweight | Phase 2 | 2025-02-12 |
| Not Yet Recruiting | A Phase I Clinical Study to Evaluate the Effect of GZR18 Injection on the Pharmacokinetics of Oral Metformin H Type 2 Diabetes | Phase 1 | 2024-10-30 |
| Completed | Pharmacokinetics and Safety Profile of a Single Dose GZR4 in Subjects with Renal Impairment Diabetes | Phase 1 | 2024-07-03 |
| Recruiting | A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injectio Type 2 Diabetes | Phase 2 | 2024-06-28 |
| Recruiting | A Study of GZR4 Injection at Different Injection Sites Healthy Subjects | Phase 1 | 2024-05-08 |
| Active Not Recruiting | A Study of GZR18 Tablet in Chinese Healthy Subjects Diabetes Mellitus, Type 2 | Phase 1 | 2024-04-01 |
| Completed | A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with Type 2 Diabetes | Phase 2 | 2023-11-21 |
| Completed | A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Di Diabetes Mellitus, Type 2 | Phase 2 | 2023-08-11 |
| Unknown | A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus Type 2 Diabetes | Phase 2 | 2023-08-09 |
| Completed | A Study of GZR18 Injection in Obese/Overweight Patients Obesity, Overweight | Phase 2 | 2023-06-08 |
| Completed | A Phase I Study of GZR18 Injection in Obese/Overweight Subjects Overweight and Obesity | Phase 1 | 2023-04-25 |
| Completed | A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Diabetes | Phase 1 | 2023-03-22 |
| Completed | A Clinical Study of GZR33 and GZR101 in Healthy Subjects Healthy Subjects | Phase 1 | 2022-12-17 |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single-dose GZR4 Diabetes | Phase 1 | 2022-08-29 |
| Completed | A Study of GZR18 Injection in Chinese Obese/Overweight Patients Obesity, Overweight | Phase 1 / Phase 2 | 2022-07-14 |
| Completed | A Study to Evaluate the Safety, Tolerance, PK and PD Parameters of GZR33 and GZR101 in Healthy Male Adult Subj Healthy Subjects | Phase 1 | 2022-06-30 |
| Completed | A Study of GZR18 Injection in Chinese Adult Patients With Type 2 Diabetes Mellitus (T2DM) Type 2 Diabetes | Phase 1 / Phase 2 | 2022-06-29 |
| Completed | Single, Ascending Dose, First Time in Human Study for GZR18 in Healthy Subjects Diabetes Mellitus, Type 2 | Phase 1 | 2022-03-08 |
| Completed | A Phase I Study of GZR18 Injection in Healthy Subjects Type 2 Diabetes, Overweight and Obesity | Phase 1 | 2021-12-02 |
| Completed | Evaluation of GLR2007 for Advanced Solid Tumors Non-small Cell Lung Cancer, Glioblastoma Multiforme | Phase 1 / Phase 2 | 2020-07-15 |
| Withdrawn | Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro Diabetes Mellitus, Type 1 | Phase 3 | 2019-12-04 |
| Completed | PK/PD Study of Gan & Lee Insulin Aspart Injection vs. US & EU NovoLog®/NovoRapid® in Healthy Males Diabetes Mellitus, Type 1 | Phase 1 | 2019-08-27 |
| Completed | PK/PD Biosimilarity Study of Gan & Lee Insulin Lispro Injection vs. EU and US Humalog® in Healthy Males Diabetes Mellitus | Phase 1 | 2019-04-23 |
| Completed | PK/PD Biosimilarity Study of Gan & Lee Insulin Glargine Injection vs.US & EU Lantus® in Type 1 Diabetes Mellit Diabetes Mellitus, Type 1 | Phase 1 | 2018-07-10 |
| Completed | Gan & Lee Insulin Glargine Target Type (2) Evaluating Research Diabetes Mellitus, Type 2 | Phase 3 | 2017-10-31 |
| Completed | Gan & Lee Insulin Glargine Target Type (1) Evaluating Research Diabetes Mellitus, Type 1 | Phase 3 | 2017-10-31 |
| Completed | PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes Diabetes Mellitus, Type 1 | Phase 1 | 2015-12-01 |